Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea

COVID-19 was declared a “Public Health Emergency of International Concern” in March 2020. Since then, drastic measures were implemented to reduce the virus spread. These measures prevented cancer patients from receiving prompt medical care. A delay in testing and treating cancer patients is thought...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutros, Marc, Moujaess, Elissar, Kourie, Hampig Raphael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959683/
https://www.ncbi.nlm.nih.gov/pubmed/33737160
http://dx.doi.org/10.1016/j.critrevonc.2021.103273
_version_ 1783665002445537280
author Boutros, Marc
Moujaess, Elissar
Kourie, Hampig Raphael
author_facet Boutros, Marc
Moujaess, Elissar
Kourie, Hampig Raphael
author_sort Boutros, Marc
collection PubMed
description COVID-19 was declared a “Public Health Emergency of International Concern” in March 2020. Since then, drastic measures were implemented to reduce the virus spread. These measures prevented cancer patients from receiving prompt medical care. A delay in testing and treating cancer patients is thought to protect them from serious COVID-19 complications but exposes them at the same time to the risk of disease progression and cancer related mortality. Healthcare providers are therefore facing the dilemma of choosing between two unpleasant scenarios. To shed light upon the matter, we present in this review article, based on an extensive search of the literature, an overview of the delay in the management of cancer patients, possible contributors to this delay and its benefits and risks on cancer patients’ health.
format Online
Article
Text
id pubmed-7959683
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-79596832021-03-16 Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea Boutros, Marc Moujaess, Elissar Kourie, Hampig Raphael Crit Rev Oncol Hematol Article COVID-19 was declared a “Public Health Emergency of International Concern” in March 2020. Since then, drastic measures were implemented to reduce the virus spread. These measures prevented cancer patients from receiving prompt medical care. A delay in testing and treating cancer patients is thought to protect them from serious COVID-19 complications but exposes them at the same time to the risk of disease progression and cancer related mortality. Healthcare providers are therefore facing the dilemma of choosing between two unpleasant scenarios. To shed light upon the matter, we present in this review article, based on an extensive search of the literature, an overview of the delay in the management of cancer patients, possible contributors to this delay and its benefits and risks on cancer patients’ health. Elsevier B.V. 2021-11 2021-03-15 /pmc/articles/PMC7959683/ /pubmed/33737160 http://dx.doi.org/10.1016/j.critrevonc.2021.103273 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Boutros, Marc
Moujaess, Elissar
Kourie, Hampig Raphael
Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
title Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
title_full Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
title_fullStr Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
title_full_unstemmed Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
title_short Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
title_sort cancer management during the covid-19 pandemic: choosing between the devil and the deep blue sea
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959683/
https://www.ncbi.nlm.nih.gov/pubmed/33737160
http://dx.doi.org/10.1016/j.critrevonc.2021.103273
work_keys_str_mv AT boutrosmarc cancermanagementduringthecovid19pandemicchoosingbetweenthedevilandthedeepbluesea
AT moujaesselissar cancermanagementduringthecovid19pandemicchoosingbetweenthedevilandthedeepbluesea
AT kouriehampigraphael cancermanagementduringthecovid19pandemicchoosingbetweenthedevilandthedeepbluesea

Ejemplares similares